Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RPRX | BIIB | BNTX | ||
| Company | Royalty Pharma Plc Cl A | Biogen Inc | Biontech Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 38.92 | 173.49 | 96.18 | ||
| High | 38.93 | 175.08 | 96.75 | ||
| Low | 37.97 | 171.27 | 94.34 | ||
| Latest | 38.39 | 174.10 | 94.81 | ||
| Change | -0.42 | +1.60 | -1.19 | ||
| % Change | -1.08% | +0.93% | -1.24% | ||
| Volume | 6,350,000 | 1,781,400 | 849,000 | ||
| 20-Day Average Volume | 4,332,405 | 1,968,845 | 1,346,870 | ||
| Previous Close | 38.81 | 172.50 | 96.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 39.15 | 175.88 | 98.33 | ||
| 20-Day Raw Stochastic | 33.86% | 50.07% | 7.36% | ||
| 20-Day Relative Strength | 49.43 | 58.03 | 40.34 | ||
| Weighted Alpha | +45.34 | +27.89 | -21.37 | ||
| Today's Opinion | 80% Buy | 88% Buy | 88% Sell | ||
| Previous Opinion | 80% Buy | 88% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.37% since 12/05/25 | -3.97% since 12/05/25 | -1.50% since 12/05/25 | ||
| Low | 37.88 on 12/10/25 | 169.24 on 12/10/25 | 94.34 on 12/12/25 | ||
| High | 39.78 on 12/08/25 | 182.12 on 12/08/25 | 99.56 on 12/08/25 | ||
| 1-Month | |||||
| %Chg | -3.03% since 11/12/25 | +7.82% since 11/12/25 | -15.12% since 11/12/25 | ||
| Low | 37.31 on 11/24/25 | 161.20 on 11/13/25 | 94.00 on 11/24/25 | ||
| High | 40.50 on 12/01/25 | 185.17 on 11/24/25 | 106.75 on 11/13/25 | ||
| 3-Month | |||||
| %Chg | +5.58% since 09/12/25 | +20.19% since 09/12/25 | -2.00% since 09/12/25 | ||
| Low | 34.63 on 09/26/25 | 135.39 on 09/29/25 | 94.00 on 11/24/25 | ||
| High | 41.24 on 11/06/25 | 185.17 on 11/24/25 | 113.39 on 11/12/25 | ||
| 6-Month | |||||
| %Chg | +8.85% since 06/12/25 | +31.58% since 06/12/25 | -9.64% since 06/12/25 | ||
| Low | 34.08 on 09/08/25 | 121.05 on 07/21/25 | 90.12 on 09/12/25 | ||
| High | 41.24 on 11/06/25 | 185.17 on 11/24/25 | 115.54 on 07/25/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 22,160,164 | 25,540,818 | 21,349,504 | ||
| Shares Outstanding, K | 577,238 | 146,702 | 225,182 | ||
| Annual Sales | 2,263,580,000 | 9,675,900,000 | 2,976,970,000 | ||
| Annual Net Income | 858,980,000 | 1,632,200,000 | -719,920,000 | ||
| Last Quarter Sales | 609,290,000 | 2,534,700,000 | 1,775,440,000 | ||
| Last Quarter Net Income | 288,220,000 | 466,500,000 | -33,550,000 | ||
| 60-Month Beta | 0.47 | 0.13 | 1.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.17 on 11/05/25 | 4.81 on 10/30/25 | -0.14 on 11/03/25 | ||
| Latest Earnings Date | 02/10/26 | 02/11/26 | 03/09/26 | ||
| Most Recent Dividend | 0.220 on 11/14/25 | N/A | 3.084 on 06/02/22 | ||
| Next Ex-Dividends Date | 11/14/25 | N/A | 06/02/22 | ||
| Ratios | |||||
| Price/Earnings ttm | 8.59 | 10.30 | 0.00 | ||